Sierra Acai Company
Sierra Acai Company
Open 7 Days a Week
MonaVie Independent Distributor
Distributor Training
Shop Online
Enroll Now
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
Friends
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
11-SEPTEMBER-2008 12:20:15 - Obesity Semi-protected Obesity Classification and external resources Silhouettes representing standard, overweight, and obese. ICD-10 E66. ICD-9 278 DiseasesDB 9099 MedlinePlus 003101 eMedicine med/1653 MeSH C23.888.144.699.500 Obesity is a disease in which excess body fat has accumulated to such an extent that health may be negatively affected.1 It is commonly defined as a body mass index weight divided by height squared of 30 kg/m2 or higher.1 This distinguishes it from being overweight as defined by a BMI of between 25-29.9 kg/m2.1 Obesity may be treated with dietary advice, anti-obesity drugs and in severe cases with one of several forms of bariatric surgery.23 Many studies show an association between excessive body weight and various diseases, particularly cardiovascular diseases, diabetes mellitus type 2, sleep apnea, certain types of cancer, and osteoarthritis.24 As a result, obesity has been found to reduce life expectancy.4 With rates of adult and childhood obesity increasing, authorities view it as a serious public health problem. Attempts to address it include population-wide measures to improve dietary choices and increase physical exercise.3 Contents 1 Classification 1.1 BMI 1.2 Waist circumference and waist hip ratio 1.3 Body fat percentage 1.4 Risk factors and comorbidities 2 Effects on health 2.1 Mortality 2.2 Morbidity 2.3 Obesity survival paradox 3 Causes 3.1 Dietary 3.2 Sedentary lifestyle 3.3 Genetics 3.4 Medical and psychiatric illness 3.5 Socioeconomic 4 Neurobiological mechanisms 5 Management 5.1 Diet 5.2 Exercise 5.3 Medication 5.4 Bariatric surgery 5.5 Clinical protocols 6 Epidemiology 7 Public health 8 Non-medical effects 9 History and culture 9.1 Etymology 9.2 Historical trends 9.3 Weight loss drugs 9.4 The arts 9.5 Fat acceptance movement 10 See also 11 References 12 Further reading 13 External links Classification Obesity, in absolute terms, is an increase of body adipose tissue fat tissue mass. In a practical setting it is difficult to determine this directly. Therefore obesity is typically assessed by BMI body mass index and in terms of its distribution via the waist circumference.5 In addition, the presence of obesity needs to be evaluated in the context of other risk factors such as medical conditions that could influence the risk of complications.2 BMI An obese male. Weight 146 kg/322 lbs, height 177 cm/5 ft 10 in. The body mass index is 46 kg/m2. An obese male. Weight 146 kg/322 lbs, height 177 cm/5 ft 10 in. The body mass index is 46 kg/m2. Body mass index or BMI is a simple and widely used method for estimating body fat mass.6 BMI was developed in the 19th century by the Belgian statistician and anthropometrist Adolphe Quetelet.7 BMI is an accurate reflection of body fat percentage in the majority of the adult population, but is less accurate in situations that affect body composition such as in body builders and pregnancy.2 BMI is calculated by dividing the subject's weight by the square of his/her height, typically expressed either in metric or US Customary units: Metric: BMI = kg / m2 where kg is the subject's weight in kilograms and m is the subject's height in metres. US/Customary and imperial: BMI = lb 703 / in2 where lb is the subject's weight in pounds and in is the subject's height in inches. The most commonly used definitions, established by the WHO in 1997 and published in 2000, provide the following values:1 A BMI less than 18.5 is underweight A BMI of 18.5-24.9 is normal weight A BMI of 25.0-29.9 is overweight A BMI of 30.0-34.9 is class I obesity A BMI of 35.0-39.9 is class II obesity A BMI of 40.0 is class III obesity Some modifications to the WHO definitions have been made by particular bodies:89 A BMI of 35.0 or higher in the presence of at least one other significant comorbidity is also classified by some bodies as morbid obesity. For Asians, overweight is a BMI between 23 and 29.9 kg/m2 and obesity a BMI 30 kg/m2. The surgical literature breaks down class III obesity into further catergories.10 Any BMI 40 is severe obesity A BMI of 40.0-49.9 is morbid obesity A BMI of 50 is super obese Waist circumference and waist hip ratio Main article: Central obesity In those with a BMI under 35, intra-abdominal body fat is related to negative health outcomes independent of total body fat.11 Intra-abdominal or visceral fat has a particularly strong correlation with cardiovascular disease.12 In a study of 15,000 subjects, waist circumference also correlated better with metabolic syndrome than BMI.13 Women who have abdominal obesity have a cardiovascular risk similar to that of men.14 In people with a BMI over 35, measurement of waist circumference however adds little to the predictive power of BMI as most individuals with this BMI have an abnormal waist circumferences.2 The absolute waist circumference 102 cm in men and 88 cm in women or waist-hip ratio 0.9 for men and 0.85 for women are both used as measures of central obesity.12 Body fat percentage On the left an abdominal CT of a person of normal weight. On the right an abdominal CT of an obese person. Note is made of 3.6 cm of subcutaneous fat. On the left an abdominal CT of a person of normal weight. On the right an abdominal CT of an obese person. Note is made of 3.6 cm of subcutaneous fat. Body fat percentage is total body fat expressed as a percentage of total body weight. It is generally agreed that men with more than 25% body fat and women with more than 33% body fat are obese.15 Body fat percentage can be estimated from a person's BMI by the following formula with the results being accurate to +/- 4 %. Bodyfat% = 1.2 BMI + 0.23 age - 5.4 - 10.8 gender where gender is 0 if female and 1 if male This formula takes into account the fact that the body fat percent of women is 10% greater in men then women for a given BMI and that a persons percentage body fat increases as they age even if their weight remains constant.16 Direct attempts to determine body fat percent are difficult and often expensive. One of the most accurate methods is to weigh a person underwater which is known as hydrostatic weighting. Two other simpler and less accurate methods for measuring body fat therefore have historically been used. The first is the skinfold test, in which a pinch of skin is precisely measured to determine the thickness of the subcutaneous fat layer. It has not, however, been adequately evaluated in obese subjects.16 The other is bioelectrical impedance analysis which uses electrical resistance. Bioelectrical impedance however has not been shown to provide an advantage over BMI. Therefore the routine use of these tests are discouraged.3 Body fat percent measurements techniques which are used mainly for research include computed tomography CT/CAT scan, magnetic resonance imaging MRI/NMR, and dual energy X-ray absorptiometry DEXA.11 These techniques provide very accurate measurements, although it may be difficult to scan the severely obese due weight limits of the equipment and insufficient diameter of the CT/MRI scanner.16 Risk factors and comorbidities The presence of risk factors and diseases associated with obesity are also used to establish a clinical diagnosis. Coronary heart disease, type 2 diabetes, and sleep apnea are possible complications that would indicate a need to commence or intensify treatment for obesity.2 Smoking, high blood pressure age and family history are other risk factors that, in combination with obesity, may indicate an additional reason for treatment.2 Effects on health Mortality Obesity is one of the leading preventable causes of death.17 Mortality risk varies with BMI. The lowest risk is found at a BMI of 22-24 kg/m2 and increases with changes in either direction.18 A BMI of over 32 is associated with a doubling of risk of death19 and obesity is estimated to cause an excess 111,909 to 365,000 death per year in the United States.204 Obesity on average reduces ones life expectancy by 6-7 years.214 For subjects with severe obesity BMIs 40 life expectancy is reduced by 20 years in men and 5 years in women.22 Morbidity A large number of physical and mental conditions have been associated with obesity. Health consequences can be categorized by the effects of increased fat mass osteoarthritis, obstructive sleep apnea, social stigmatization or by the increased number of fat cells diabetes, cancer, cardiovascular disease, non-alcoholic fatty liver disease.423 Increases in body fat alter the body's response to insulin leading to insulin resistance and creates a proinflammatory state and an increased risk of thrombosis.23 Central obesity, characterized by its high waist to hip ratio, is an important risk for metabolic syndrome. Metabolic syndrome is a combination of medical disorders which often includes diabetes mellitus type 2, high blood pressure, high blood cholesterol, and triglyceride levels.24 Obesity is related to a variety of other complications. Some of these are directly caused by obesity and others are indirectly related threw mechanisms such as sharing a common cause ie. poor diet or sedentary lifestyle. The strength of the link between obesity and specific conditions is variable. One of the strongest is the link with type 2 diabetes: 64% of diabetes in men and 77% of diabetes in women can be attributed to excess weight.16 System Condition System Condition Cardiovascular ischemic heart disease:12 angina and myocardial infarction congestive heart failure: 12% attributable to obesity4 high blood pressure: present in 85% of those with BMI254 high cholesterol deep vein thrombosis and pulmonary embolism25 Gastrointestinal gastroesophageal reflux disease4 fatty liver disease4 cholelithiasis gallstones hernia Endocrine and reproductive diabetes mellitus4 polycystic ovarian syndrome4 menstrual disorders4 infertility4 complications from pregnancy4 birth defects4 Respiratory obstructive sleep apnea426 obesity hypoventilation syndrome426 asthma426 complications from general anaesthesia4 Musculoskeletal hyperuricemia / gout27 immobility osteoarthritis4 low back pain Psychological Depression in women4 low self esteem body dysmorphic disorder social stigmatization4 suicide28 Neurologic stroke meralgia paresthetica headache carpal tunnel syndrome dementia29 idiopathic intracranial hypertension Skin stretch marks acanthosis nigricans lymphedema cellulitis carbuncles intertrigo Cancer30 breast esophageal colorectal liver gallbladder pancreatic stomach, prostate endometrial, cervical ovarian kidney non-Hodgkin's lymphoma multiple myeloma Genitourinary erectile dysfunction31 urinary incontinence chronic renal failure32 hypogonadism33 stillbirth Obesity survival paradox Although the negative health consequences of obesity in the general population are well supported by the available evidence, health outcomes in certain subgroups seem to be improved at an increased BMI, thus leading to the obesity survival paradox.34 The paradox was first described in 1999 in overweight and obese patients undergoing hemodialysis. Since then it has been found in a few other subgroups and explanations for its occurrence have been put forwards.34 In people with heart failure, those with a BMI between 30.0-34.9 had lower mortality then those with a normal weight. This has been attributed to the fact that people often lose weight as they become progressively more ill.35 Similar findings have been make in other types of heart disease. People with class I obesity and heart disease do not have greater rates of further heart problems than people of normal weight who also have heart disease. In people with greater degrees of obesity, however, risk of further events is increased.3637 Even after cardiac bypass surgery, no increase in mortality is seen in the overweight and obese.38 One study found that the increased survival could be explained by the more aggressive treatment obese people receive after a cardiac event.39 Causes Most researchers agree that a combination of excessive calorie consumption and a sedentary lifestyle are the primary causes of obesity.40 In a minority of cases, increased food consumption can be attributed to genetic, medical, or psychiatric illness, but in general the rising prevalence of obesity is attributed to the availability of an easily accessible and palatable diet,41 car culture, and mechanized manufacturing. A 2006 review identifies ten other possible contributors to the recent increase of obesity: 1 insufficient sleep, 2 endocrine disruptors - food substances that interfere with lipid metabolism, 3 decreased variability in ambient temperature, 4 decreased rates of smoking, which suppresses appetite, 5 increased use of medication that leads to weight gain, 6 increased distribution of ethnic and age groups that tend to be heavier, 7 pregnancy at a later age, 8 intrauterine and intergenerational effects, 9 positive natural selection of people with a higher BMI, 10 assortative mating, heavier people tending to form relationships with each other.42 Dietary USDA chart shows the increase in soda consumption and the decrease in milk consumption. USDA chart shows the increase in soda consumption and the decrease in milk consumption. Despite the widespread availability of nutritional information in schools, doctors' offices, on the internet and on product packaging,43 it is evident that overeating remains a substantial problem. In the period of 1971-2000, obesity rates in the United States increased from 14.5% to 30.9%.44 During the same time period, an increase occurred in the average amount of calories consumed. For women, the average increase was 335 calories per day 1542 calories in 1971 and 1877 calories in 2004, while for men the average increase was 168 calories per day 2450 calories in 1971 and 2618 calories in 2004. Most of these extra calories came from an increase in carbohydrate consumption rather than an increase in fat consumption.45 The primary sources of these extra carbohydrates are sweetened beverages, which now accounts for almost 25 percent of daily calories in young adults.46 Dietary trends have changed with reliance on energy-dense fast-food meals tripling between 1977 and 1995, and calorie intake from fast food quadrupling over the same period.47 In the early 1980s the administration of Reagan lifted regulations limiting the advertising of sweets and fast food to children. The advertisements of these products directed at children has thus increased.48 Agricultural policy and techniques in the United States and Europe have led to lower food prices. In the United States, subsidization of corn, soy, wheat, and rice through the U.S. farm bill has made the main sources of processed food relatively cheap compared to fruits and vegetables.49 There is little evidence to support the commonly expressed view that some obese people eat little yet gain weight due to a slow metabolism. What has been found, however, is that some obese people underreport how much food they consume compared to those of normal weight.16 Sedentary lifestyle A sedentary lifestyle plays a significant role in obesity.16 In 2000 the CDC estimated that more than 40% of the US population was sedentary, another 30% was active but not sufficiently and less than 30% had an adequate level of physical activity.46 There has been a trend toward decreased physical activity in part due to increasingly mechanized forms of work, changing modes of transportation, and increasing urbanization. Studies in children and adults have found an association between the number of hours of television watched and the prevalence of obesity.505152 Driving one's children to school decreases the amount of exercise that they get. This is reflected in the decline in the proportion of children who walk or bike to school which occurred between 1969 42% and 2001 16% in the USA.46 Obese people are less active than those of normal weight. For example in Canada, 27.0% of sedentary men are obese as opposed to 19.6% of active men.53 Normal weight people are also more fidgety then those who are obese. This relationship is maintained even if normal weight people eat more or the obese person loses weight.54 Obesity rates have increased in relation to expanding suburbs. This has been attributed to increased time spent commuting, leading to less exercise and less meal preparation at home.55 Genetics Like many other medical conditions, obesity is the result of an interplay between genetic and environmental factors. Polymorphisms in various genes controlling appetite and metabolism may predispose to obesity when sufficient calories are present. Obesity is a major feature in a number of rare genetic conditions: Prader-Willi syndrome, Bardet-Biedl syndrome, MOMO syndrome, leptin receptor mutations, congenital leptin deficiency, and melanocortin receptor mutations. In a people with early-onset severe obesity defined by an onset before ten years of age and body mass index over three standard deviations above normal, 7% harbor a single locus mutation.56 Apart from the above syndromes, an association has been found between an FTO gene polymorphism and weight. The 16% of adults in the study who were homozygous for this allele weighed about 3 kilograms more then those who had not inhereted this trait and subsequently had a 1.6 fold greater rate of obesity.57 One study found that 80% of the offspring of two obese parents were obese in contrast to less then 10% of the offspring of two parents who were of normal weight.2816 The association disappeared, though, when those with FTO polymorphisms participated in above-average physical exercise.58 The percentage of obesity that can be attributed to genetics varies from 6% to 85% depending on the population examined.59 On a population level, the thrifty gene hypothesis postulates that certain ethnic groups may be more prone to obesity when exposed to an equivalent environment. Their ability to take advantage of rare periods of abundance by storing energy as fat would be advantagious during times of varying food availability. Individuals with greater adipose reserves would be more likely survive famine. This tendency to store fat however would be maladaptive in societies with stable food supplies.60 This is the presumed reason why Pima Indians, who evolved in a desert ecosystem, developed some of the highest rates of obesity when exposed to a Western lifestyle.41 Medical and psychiatric illness Certain physical and mental illnesses and the pharmaceutical substances used to treat them can increase one's risk of obesity. Medical illnesses that increase obesity risk include several rare genetic syndromes listed above as well as some congenital or acquired conditions: 1 hypothyroidism, 2 Cushing's syndrome, 3 growth hormone deficiency,61 and 4eating disorders: binge eating disorder and night eating syndrome.4 However, obesity is not regarded as a psychiatric disorder, and therefore is not listed in the DSM-IVR as a psychiatric illness.28 Certain medications may cause weight gain and or negative changes in body composition, such as insulin, sulfonylureas, thiazolidinediones, atypical antipsychotics, antidepressants, steroids, sulfonylureas, certain anticonvulsants phenytoin and valproate, pizotifen, and some forms of hormonal contraception.4 Socioeconomic While genetic influences are important to understanding obesity, they cannot explain the current dramatic increase seen within specific countries or globally.41 Though it is accepted that calorie consumption in excess of calorie expenditure leads to obesity on an individual basis, the cause of the shifts in these two factors on the societal scale is much debated. There are a number of theories as to the cause but most believe it is a combination of various factors. The correlation between social class and BMI varies globally. A review in 1989 found that in developed countries women of a high social class were less likely to be obese. No significant difference were seen among men of different social classes. In the developing world, women, men, and children from high social classes had greater rates of obesity.62 An update of this review was carried out in 2007 and found the same relationships but they were less strong. The decrease in strength of correlation were felt to be due to the effects of globilization.63 Many explanations have been put forth for associations between BMI and social class. It is thought that in developed countries, the wealthy are able to afford more nutricious food, they are under greater social pressure to remain slim, and have more opportunities along with greater expectations for physical fitness. In the developing world the ability to afford food, high energy expenditure with physical labor, and cultural values favoring a larger body size are believed to contribute to the observed patterns.63 The acceptance of body mass by people in one's life may also play a role in obesity. A correlation in BMI changes over time has been found between friends, siblings, and spouses.64 Smoking has a significant affect on weight. Those who quit smoking gain on average 4-5 kilograms over ten years. One sixth of the rise in obesity in North Americans can be attributed to falling rates of smoking, although the health benefits of quitting smoking are considered undeniable.65 Neurobiological mechanisms On the left a mouse unable to produce leptin resulting in obesity. On the right a normal mouse for comparison. On the left a mouse unable to produce leptin resulting in obesity. On the right a normal mouse for comparison. Flier summarizes the many possible pathophysiological mechanisms involved in the development and maintenance of obesity.66 This field of research had been almost unapproached until leptin was discovered in 1994. Since this discovery, many other hormonal mechanisms have been elucidated that participate in the regulation of appetite and food intake, storage patterns of adipose tissue, and development of insulin resistance. Since leptin's discovery, ghrelin, orexin, PYY 3-36, cholecystokinin, adiponectin, as well as many other mediators have been studied. The adipokines are mediators produced by adipose tissue; their action is thought to modify many obesity-related diseases. Leptin and ghrelin are considered to be complementary in their influence on appetite, with ghrelin produced by the stomach modulating short-term appetitive control i.e. to eat when the stomach is empty and to stop when the stomach is stretched. Leptin is produced by adipose tissue to signal fat storage reserves in the body, and mediates long-term appetitive controls i.e. to eat more when fat storages are low and less when fat storages are high. Although administration of leptin may be effective in a small subset of obese individuals who are leptin deficient, most obese individuals are thought to be leptin resistant and have been found to have high levels of leptin.67 This resistance is thought to explain in part why administration of leptin has not been shown to be effective in suppressing appetite in most obese subjects.66 While leptin and ghrelin are produced peripherally, they control appetite through their actions on the central nervous system. In particular, they and other appetite-related hormones act on the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure. There are several circuits within the hypothalamus that contribute to its role in integrating appetite, the melanocortin pathway being the most well understood.66 The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus LH and ventromedial hypothalamus VMH, the brain's feeding and satiety centers, respectively.68 The arcuate nucleus contains two distinct groups of neurons.66 The first group coexpresses neuropeptide Y NPY and agouti-related peptide AgRP and has stimulatory inputs to the LH and inhibitory inputs to the VMH. The second group coexpresses pro-opiomelanocortin POMC and cocaine- and amphetamine-regulated transcript CART and has stimulatory inputs to the VMH and inhibitory inputs to the LH. Consequently, NPY/AgRP neurons stimulate feeding and inhibit satiety, while POMC/CART neurons stimulate satiety and inhibit feeding. Both groups of arcuate nucleus neurons are regulated in part by leptin. Leptin inhibits the NPY/AgRP group while stimulating the POMC/CART group. Thus a deficiency in leptin signaling, either via leptin deficiency or leptin resistance, leads to overfeeding and may account for some genetic and acquired forms of obesity.66 Management Main article: Weight loss The main treatment for obesity consists of eating less and exercising more. Diet programs may produce weight loss over the short term,69 but keeping this weight off can be a problem. It often requires making exercise and a lower calorie diet a permanent part of a person's lifestyle.7071 In the general population only 20% are successful at long-term weight loss maintenance.72 In a more structured setting, however, 67% of people who lost greater then 10% of their body mass maintained or continued to lose weight one year later.73 An average maintained weight loss of more then 3 kg or 3% of total body mass could be sustained for five years.74 There are significant benefits to weight loss. In a prospective study, intentional weight loss of any amount was associated with a 20% reduction in all-cause mortality.75 Diet Main article: Dieting Diets to promote weight loss are generally divided into four categories low-calorie, low-fat, low-carbohydrate, and very low calorie.69 Low calorie diets usually produce an energy deficit of 500-1000 calories per day, which can result in a 0.5 kilogram weight loss per week. They include the DASH diet and Weight Watchers among others. The National Institutes of Health reviewed 34 randomized controlled trials to determine the effectiveness of low-calorie diets. They found that these diet lowered total body mass by 8% over 3-12 months.69 Low fat diets involve the reduction of the percentage of fat in ones diet. Calorie consumption is reduced but not purposely so. Diets of this type include NCEP Step I and II. A meta-analysis of 16 trials of 2-12 months duration found that low-fat diets resulted in weight loss of 3.2 kg over eating as normal.69 Low carbohydrate diets are relatively high in fat and protein. They are very popular in the press however are not recommenced by the American Heart Association. Diets of this type include Atkins and Protein Power. A review of 94 trials found that weight loss was associated with decreased calorie consumption rather than any special properties of reduced carbohydrate consumption. No adverse affect from low carbohydrate diets were detected.76 A further meta-analysis of 6 randomized controlled trials found no difference between the main diet types low calorie, low carbohydrate, and low fat, with a 2-4 kilogram weight loss in all studies.69 Very low calorie diets maintain protein intake while limiting calories from both fat and carbohydrates. They subject the body to starvation and produce average weekly weight loss of 1.5-2.5 kilograms. These diets are not recommended for general use as they are associated with adverse side effect such as loss of lean muscle mass, increased risks of gout, and electrolyte imbalances. People attempting these diets must be monitored closely by a physician to prevent complications.69 Exercise Main article: Physical exercise With use, muscles consume energy derived from both fat and glycogen. Due to the large size of leg muscles walking, running, and cycling are the most effective means of exercise to reduce body fat.7778 A meta-analysis of 43 randomized controlled trials by the Cochrane Collaboration found that exercising alone led to limited weight loss. In combination with diet, however, it resulted in a 1 kilogram weight loss over dieting alone. A 1.5 kilogram loss was observed with a greater degree of exercise.79 Even though exercise as carried out in the general population has only modest effects a dose response curve is found and very intense exercise can lead to substantial weight loss. During 20 weeks of basic military training with no dietary restriction obese military recruit lost 12.5 kg.80 Medication Main article: Anti-obesity drug There are two commonly prescribed medications for obesity. One is orlistat, which reduces intestinal fat absorption by inhibiting pancreatic lipase; the other is sibutramine, which is a specific inhibitor of norepinephrine, serotonin, and dopamine in the brain,therefore decreasing appetite. Rimonabant, a third drug, works via a specific blockade of the endocannabinoid system. It has been approved in Europe for the treatment of obesity but has not yet received approval in the United States due to concerns about its safety.81 Weight loss with these drugs is modest, and over the longer term average weight loss on orlistat is 2.9 kg, sibutramine is 4.2 kg and rimonabant is 4.7 kg. Orlistat and rimonabant lead to a reduced incidence of diabetes, and all drugs have some effect on cholesterol. There is little data on how these drugs affect the longer-term complications of obesity.82 It is common for weight loss drugs to be tried and if there is little or no benefit from them to discontinue treatment.3 A meta-analysis of randomized controlled trials by the Cochrane Collaboration concluded that in diabetic patients fluoxetine, orlistat and sibutramine could achieve modest but significant weight loss over 12-57 weeks. The long-term health benefits remained unclear.83 Obesity may also influence the choice of drugs used to treat diabetes. Metformin may lead to mild weight loss in comparison to sulfonylureas and insulin. It has been show to reduce the risk of cardiovascular disease in type 2 diabetics who are obese.84 The thiazolidinediones on the other hand may cause some weight gain, but decrease central obesity and therefore can be used in obese diabetics.85 EphedrineMa Huang is a stimulant effective for weight loss however it is not recommended due to potential side effects.86 Bariatric surgery Main article: bariatric surgery Bariatric surgery or weight loss surgery is the use of surgical interventions in the treatment of obesity. As every operation may have complications, surgery is only recommended for those with more severe obesity BMI 40 who has failed to loss weight with dietary modification and pharmacological treatment. Weight loss surgery relies on various principles; the most common approaches are reducing the volume of the stomach, producing an earlier sense of satiation e.g. by adjustable gastric banding and vertical banded gastroplasty while others also reduce the length of bowel that food will be in contact with, directly reducing absorption gastric bypass surgery. Band surgery is reversible, while bowel shortening operations are not. Some procedures can be performed laparoscopically. Complications from weight loss surgery are frequent.87 Surgery for severe obesity is associated with long-term weight loss and decreased overall mortality. A controlled prospective study carried out in Sweden involving 4,047 people found a weight loss of between 14% and 25% at 10 years depending on the type of procedure performed and a 29% reduction in all cause mortality when compared to standard weight lose measures.88 A marked decrease in the risk of diabetes mellitus, cardiovascular disease and cancer has also been found after bariatric sugery.8990 Weight loss is marked in the first few months after surgery and is sustained in the long term. In one study there was an unexplained increase in deaths from accidents and suicide but this did not outweigh the benefit in terms of disease prevention. When comparisons are made between the procedures gastric bypass surgery is found to be about twice as effective as banding procedures.90 The effects of liposuction however are less well determined with some small studying showing no benefits91 and others showing benefits.92 Clinical protocols In a clinical practice guideline by the American College of Physicians, the following five recommendations are made:93 People with a BMI of over 30 should be counseled on diet, exercise and other relevant behavioral interventions, and set a realistic goal for weight loss. If these goals are not achieved, pharmacotherapy can be offered. The patient needs to be informed of the possibility of side-effects and the unavailability of long-term safety and efficacy data. Drug therapy may consist of sibutramine, orlistat, phentermine, diethylpropion, fluoxetine, and bupropion. For more severe cases of obesity, stronger drugs such as amphetamine and methamphetamine may be used on a selective basis. Evidence is not sufficient to recommend sertraline, topiramate, or zonisamide. In patients with BMI 40 who fail to achieve their weight loss goals with or without medication and who develop obesity-related complications, referral for bariatric surgery may be indicated. The patient needs to be aware of the potential complications. Those requiring bariatric surgery should be referred to high-volume referral centers, as the evidence suggests that surgeons who frequently perform these procedures have fewer complications. A clinical practice guideline by the US Preventive Services Task Force USPSTF concluded that the evidence is insufficient to recommend for or against routine behavioral counseling to promote a healthy diet in unselected patients in primary care settings, but that intensive behavioral dietary counseling is recommended in those with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease. Intensive counseling can be delivered by primary care clinicians or by referral to other specialists, such as nutritionists or dietitians.9495 Epidemiology Obesity rates as a percentages of total population in OECD member countries in the years 1996-2003. Obesity rates as a percentages of total population in OECD member countries in the years 1996-2003.96 The global nature of the obesity epidemic was formally recognized by the World Health Organization in 1997.46 As of 2005 the WHO estimates that at least 400 million adults 9.8% are obese with rates being higher among women then men.1 Once considered a problem only of high-income countries, rate of obesity are rising world wide. These increases have been felt most dramatically in urban settings.1 The only remaining region of the world were obesity is not common is sub-Saharan Africa.4 The rate of obesity is also seen to increase with age at least up to 50 or 60 years old.16 Australia Studies conducted in 2006 found that close to 52% of Australian women and up to 67% of Australian men aged 25 or over are overweight or obese.97 Canada The number of Canadians who are obese has risen dramatically in recent years. In 2004, direct measurements of height and weight found 23.1% of Canadians older then 18 had a BMI greater then 30. When broken down into degrees of obesity 15.2% were Class I BMI 30-34.9, 5.1% were Class II BMI 35-39.9, and 2.7%, Class III BMI 40. This is in contrast to self reported data the year previous of 15.2% and in 1978/1979 of 13.8%. The greatest increases occurred among the more severe degrees of obesity, Class III obesity increased from 0.9% to 2.7% from 1978/1979 to 2004. Obesity in Canada varies by ethnicity with people of Aboriginal origin having a significantly higher rate of obesity rate 37.6% then the national average.53 European Union Between the 1970s and the 2000s, rates of obesity in most European countries has increased. During the 1990s/2000s the 27 countries making up the EU reported rates of obesity from 10% to 27% in men and from 10% to 38% in women.98 India Main article: Obesity in India In India urbanization and modernizations has been associated with obesity. As of 1999 in northern Indian 11% of urban women were found to be obese in contrast to 3.7% of rural women. Well women of high socioeconmic class had a rate of obesity of 10.4% as oppose to a rate of 0.9% in women of low socioeconomic class.99 With people moving into urban centers and wealth increasing, concerns about an obesity epidemic in India are growing. China Because of the booming economy increasing average incomes, the population of China has recently begun a more sedentary lifestyle and at the same time begun consuming more calorie-rich foods. From 1991 to 2004 the percentage of adults who are overweight or obese increased from 12.9% to 27.3%.100 Mexico Main article: Obesity in Mexico Mexico has the second highest rate of obesity in the developed world at 24.2% of the population.96 South Pacific Many of the island nations of the South Pacific have very high rates of obesity. Nauru has the highest rates of obesity in the world 80% followed by Tonga, the Federated States of Micronesia, and the Cook Islands. Being big has traditionally been associated with health, beauty, and status and many of these beliefs remain prevalent today.101 United Kingdom In the UK the rate of obesity has increased about fourfold over the last 25 years reaching current levels of 22%.16 The Health Survey for England predicts that more than 12 million adults and 1 million children will be obese by 2010 if no action is taken.102103 United States Main article: Obesity in the United States Percentage of the US population classified as obese according to the CDC, as of April 17, 2007. 31.0-34.0% 28.0-30.9% 25.0-27.9% 22.0-24.9% 19.0-21.9% Percentage of the US population classified as obese according to the CDC, as of April 17, 2007. 31.0-34.0% 28.0-30.9% 25.0-27.9% 22.0-24.9% 19.0-21.9% The United States has the highest rates of obesity in the developed world.96 From 1980 to 2002, obesity rates have doubled reaching the current rate of 32% of the adults population.104 Rate of obesity vary by ethnicity and gender. In the USA 28% of men and 34% of women are obese with rates rising to as high as 50% among African American women.105 The prevalence of class 3 obesity BMI ≥40 has increased the most dramatically from 0.78 percent in 1990 to 2.2 percent in 2000.106 Public health Obesity is a public health and policy problem because of its prevalence, costs, and health effects.107 Public health efforts seek to understand and correct the environmental factors responsible for the increasing prevalence of obesity in the population. Solutions look at changing the factors that cause excess calorie consumption and inhibit physical activity. Efforts include federally-reimbursed meal programs in schools, limiting direct junk food marketing to children,108 and decreasing school time access to sweetened beverages.109 When constructing urban environments effort have been made to increase access to parks and develop pedestrian routes.110 Many countries and groups have published reports pertaining to obesity. In 1998 the first US Federal guidelines were published the Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report.2 In 2006 the Canadian Obesity Network published the Canadian Clinical Practice Guidelines CPG on the Management and Prevention of Obesity in Adults and Children. This is a comprehensive evidence-based guideline to address the management and prevention of overweight and obesity in adults and children.111 In 2004, the United Kingdom Royal College of Physicians, the Faculty of Public Health and the Royal College of Paediatrics and Child Health released the report Storing up Problems, which highlighted the growing problem of obesity in the UK.112 The same year, the House of Commons Health Select Committee published its most comprehensive inquiry ... ever undertaken into the impact of obesity on health and society in the UK and possible approaches to the problem.113 In 2006, the National Institute for Health and Clinical Excellence NICE issued a guideline on the diagnosis and management of obesity, as well as policy implications for non-healthcare organizations such as local councils.3 A 2007 report produced by Sir Derek Wanless for the King's Fund warned that unless further action was taken, obesity had the capacity to cripple the National Health Service financially.114 Non-medical effects Some U.S. Kaiser Permanente facilities now provide oversized chairs such as this one at Richmond Medical Center for obese patients. Some U.S. Kaiser Permanente facilities now provide oversized chairs such as this one at Richmond Medical Center for obese patients. Obesity leads to many other problems other than its impact on an individual's health. These effects are felt by all levels of society from governments, to corporations, to individuals. It lead to increased business costs, social stigmatization, and disadvantages in employment.16 Obesity and its health effects create sizable societal economic costs, with medical costs attributable to obesity rising to US$78.5 billion, or 9.1% of all medical expenditures in the U.S. as of 1998.115116 One recent study, however, found that while obesity prevention programs reduce the cost of treating diseases related to obesity, those reductions are offset by medical costs during the additional years of life gained. The authors conclude that reducing obesity may improve public health, but is unlikely to reduce overall health spending.117 Worker costs rise and productivity is impaired, as measured by usage of disability leave and absenteeism at work.118 A study examining Duke University employees found that those with a BMI40 filed twice as many workers compensation claims as workers whose BMI was 18.5-24.9, and had more than 12 times as many lost work days. The most common injuries were due to falls and lifting, and affected the lower extremities, wrists or hands, and backs.119 Due to obesity airlines face higher fuel costs, as well as pressure to increase seating width. In 2000, the extra weight of obese passengers cost airlines and consumers US$275 million.120 Costs are also increased by litigation by obese persons suing restaurants for causing obesity121 and airlines over airline seating width.122 In 2005 the US Congress discussed legislation to prevent civil law suit being brought against the food industry in relation to obesity. It however did not become law.121 The US state of Alabama Employees' Insurance Board approved a controversial plan to charge obese workers $25 per month if they do not take measures to reduce their weight and improve their health. These measures are set to start Jan. 2010 and apply to those with a BMI of greater then 35 kg/m^2 who fail to make improvements in their health after one year.123 Obese employees are paid less then their non obese counterparts for the equivalent job. Obese women on average make 6% less well obese men make 3% less.16 History and culture Etymology Obesity is the nominal form of obese which comes from the Latin obÄ“sus, which means stout, fat, or plump. Ä’sus is the past participle of edere to eat, with ob added to it. In Classical Latin, this verb is seen only in past participial form. Its first attested usage in English was in 1651, in Noah Biggs's Matæotechnia Medicinæ Praxeos.124 Historical trends Obesity was a status symbol in renaissance culture: The Tuscan General Alessandro del Borro, 1645. Obesity was a status symbol in renaissance culture: The Tuscan General Alessandro del Borro, 1645.125 Obesity has been recognized as a medical disorder at least since the time of Hippocrates when he stated that Corpulence is not only a disease itself, but the harbinger of others.4 For most of human history mankind struggled with food scarcity. With the onset of the industrial revolution it was realized that the military and economic might of nations were dependent on both the body size and strength of its soldiers and workers. Increasing the average body mass index from underweight to the normal range playing a significant role in the development of industrialized societies. Height and weight thus both increased though the 19th century in the developed world. During the 20th century, as populations reached their genetic potential for height, weight began increasing much more than height, resulting in obesity.46 In the 1950s increasing wealth in the developed world decreased child mortality but as body weight increased heart and kidney disease became more common.46126 During this same time period insurance companies realized the connection between weight and life expectancy and increased premiums of the obese.4 Many cultures through out history have viewed obesity as a flaw. The obesus or fat character in Greek comedy was a glutton and figure of mockery. During Christian times food was viewed as a gateway to the sins of sloth and lust.127 In Western culture, excess weight is often regarded as unattractive, and obesity is commonly associated with various negative stereotypes. All ages can face social stigmatization and may be targeted by bullies or shunned by their peers. In Western culture obesity is once again seen as a sign off a low socio-economic status.128 Obese people are less likely to be hired for a job, make less money when they are hired, and are less likely to be promoted.28 The weight that is viewed by many as an ideal has become less over the last 75 years. The average heights of Miss America pageant winners increased by 2 % from 1922 to 1999 well at the same time her weight decreased by 12%.28 Weight loss drugs The first described attempts at producing weight loss are those of Soranus of Ephesus, a Greek physician, in the second century AD. He prescribed elixirs of laxatives and purgatives, as well as heat, massage, and exercise. This remained the mainstay of treatment for well over a thousand years. It was not until the 1920s and 1930s that new treatments began to appear. Based on its effectiveness for hypothyroidism, thyroid hormone became a popular treatment for obesity in otherwise healthy people. It had a modest effect but produced the symptoms of hyperthyroidism as a side effect, such as palpitations and difficulty sleeping. Dinitrophenol DNP was introduced in 1933; this worked by uncoupling the biological process of oxidative phosphorylation in mitochondria, causing them to produce heat instead of ATP. The most significant side-effect was a dramatic rise in body temperature, frequently causing death. By the end of the 1930s DNP had fallen out of use.41 Amphetamines marketed as Benzedrine became popular for weight loss during the late 1930s. They worked primarily by suppressing appetite and had other beneficial effects such as increased alertness. Use of amphetamines increased over the subsequent decades, culminating in the rainbow pill regime. This was a combination of multiple pills, all thought to help with weight loss, taken throughout the day. Typical regimens included stimulants, such as amphetamines and thyroid hormone, diuretics, digitalis, laxatives, and often a barbiturate suppress the side effects of the stimulants. In 1967/1968 a number of deaths attributed to diet pills triggered a Senate investigation and the gradual implementation of greater restrictions on the market. This culminating in 1979 with the FDA banning the use of amphetamines, then the most effective of the diet drugs, in diet pills.41 Meanwhile, phentermine had been FDA approved in 1959 and fenfluramine in 1973. The two were no more popular then other drugs until in 1992 a researcher reported that the two caused a 10% weight loss which was maintained for over two years.129 Fen-phen was born and rapidly became the most commonly prescribed diet medication. Dexfenfluramine Redux was developed in the mid-1990s as an alternative to fenfluramine with less side-effects, and received regulatory approval in 1996. However, this coincided with mounting evidence that the combination could cause valvular heart disease in up to 30% of those who had taken it, leading to withdrawal of Fen-phen and dexfenfluramine from the market in September 1997.41 Ephedra was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death.28 The arts Venus of Willendorf created 24,000-22,000 BC Venus of Willendorf created 24,000-22,000 BC The first sculptural representations of the human body 20,000 - 35,000 years ago depict obese females. Some attribute the Venus figurines to the tendency to emphasize characteristics that portray fertility while others feel these could be actual representations of the people at the time. Corpulence is however absent in both Greek and Roman art, probably fitting with their ideals of moderation. This continued through much of Christian European history with only those of low socioeconomic status being depicted as obese. During the Renaissance some of the upper class began flaunting their size. This can be seen in portraits of Henry the VIII and Alessandro del Borro.127 Rubens 1577-1640 regularly depicted full bodied women in his pictures, from which derives the term Rubenesque. These women however still maintained the hourglass shape with its relationship to fertility.78 During the 19th century, views on obesity changed in the Western world. After centuries of obesity being synonymous with wealth and social status, slimness began to be seen as the desirable standard.127 Fat acceptance movement Main article: Fat acceptance movement A small vocal fat acceptance movement is attempting to challenge the established relationship between obesity, diet and exercise, and the negative health outcomes that result. The National Association to Advance Fat Acceptance NAAFA was formed in 1969 and describes itself as a civil rights organization dedicated to ending size discrimination.130 Multiple books such as The Diet Myth by Paul Campos argue that the health risks of obesity are a conspiracy and the real problem is social stigma facing the obese.131 Similarly, The Obesity Epidemic by Michael Gard argues that obesity is a moral and ideological construct.132 Some people are attracted to the obese. Chubby culture133 and fat admirers134 have become recognized subcultures during the last few decades. See also Childhood obesity Overweight Body image Healthy diet Human weight Junk food List of the most obese humans National Weight Control Registry New World Syndrome Physical exercise Pickwickian syndrome Overeaters Anonymous References ^ a b c d e f World Health Organization 2000. Technical report series 894: Obesity: preventing and managing the global epidemic. PDF, Geneva: World Health Organization. ISBN 92-4-120894-5. ^ a b c d e f g h National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. International Medical Publishing, Inc. ISBN 1-58808-002-1. ^ a b c d e National Institute for Health and Clinical Excellence. Clinical guideline 43: Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London, 2006. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa Haslam DW, James WP 2005. Obesity. Lancet 366 9492: 1197-209. doi:10.1016/S0140-67360567483-1. PMID 16198769. ^ Sweeting HN 2007. Measurement and definitions of obesity in childhood and adolescence: a field guide for the uninitiated. Nutr J 6: 32. doi:10.1186/1475-2891-6-32. PMID 17963490. ^ Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH 2002. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 75: 978-85. PMID 12036802. ^ Quetelet LAJ 1871. Antropométrie ou Mesure des Différences Facultés de l'Homme. Brussels: Musquardt. ^ NICE issues guidance on surgery for morbid obesity. National Institute for Health and Clinical Excellence 19 July 2002. Retrieved on 2007-03-08. ^ Bariatric Surgery. USC Center for Colorectal and Pelvic Floor Disorders. University of Southern California 2006. Retrieved on 2007-03-08. ^ Emedicine|http://www.emedicine.com/med/TOPIC1653.HTM ^ a b U.S. Preventive Services Task Force Evidence Syntheses 2000. HSTAT: Guide to Clinical Preventive Services, 3rd ion: Recommendations and Systematic Evidence Reviews, Guide to Community Preventive Services. ISBN url=http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.section.36199. ^ a b c Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries the INTERHEART study: case-control study. Lancet 364: 937-52. doi:10.1016/S0140-67360417018-9. PMID 15364185. ^ Janssen I, Katzmarzyk PT, Ross R 2004. Waist circumference and not body mass index explains obesity-related health risk. Am. J. Clin. Nutr. 79 3: 379-84. doi:10.1185/030079906X159489. PMID 14985210. ^ Larsson B, Bengtsson C, Björntorp P et al Feb 1992. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol 135 3: 266-73. PMID 1546702. ^ emedicine|http://www.emedicine.com/med/TOPIC1653.HTM ^ a b c d e f g h i j k Peter G. Kopelman, Ian D. Caterson, Michael J. Stock, William H. Dietz 2005. Clinical obesity in adults and children: In Adults and Children. Blackwell Publishing, 493. ISBN 140-511672-2. ^ Mokdad AH, Marks JS, Stroup DF, Gerberding JL March 2004. Actual causes of death in the United States, 2000. JAMA 291 10: 1238-45. doi:10.1001/jama.291.10.1238. PMID 15010446. ^ Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW October 1999. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341 15: 1097-105. PMID 10511607. ^ Manson JE, Willett WC, Stampfer MJ, et al 1995. Body weight and mortality among women. N. Engl. J. Med. 333 11: 677-85. doi:10.1056/NEJM199509143331101. PMID 7637744. ^ Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB October 1999. Annual deaths attributable to obesity in the United States. JAMA 282 16: 1530-8. PMID 10546692. ^ Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L January 2003. Obesity in adulthood and its consequences for life expectancy: a life-table analysis PDF. Ann. Intern. Med. 138 1: 24-32. PMID 12513041. ^ Emedicine|http://www.emedicine.com/med/TOPIC1653.HTM ^ a b Bray GA 2004. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 89 6: 2583-9. doi:10.1210/jc.2004-0535. PMID 15181027. ^ Grundy SM 2004. Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 89 6: 2595-600. doi:10.1210/jc.2004-0372. PMID 15181029. ^ Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ February 2007. Obesity and thrombosis. Eur J Vasc Endovasc Surg 33 2: 223-33. doi:10.1016/j.ejvs.2006.10.006. PMID 17185009. ^ a b c Poulain M, Doucet M, Major GC, et al April 2006. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 174 9: 1293-9. doi:10.1503/cmaj.051299. PMID 16636330. PMC:1435949. ^ Choi HK, Atkinson K, Karlson EW, Curhan G April 2005. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch. Intern. Med. 165 7: 742-8. doi:10.1001/archinte.165.7.742. PMID 15824292. ^ a b c d e f Kolata,Gina 2007. Rethinking Thin: The new science of weight loss - and the myths and realities of dieting. Picador. ISBN 0-312-42785-9. ^ Beydoun MA, Beydoun HA, Wang Y May 2008. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 9 3: 204-18. doi:10.1111/j.1467-789X.2008.00473.x. PMID 18331422. ^ Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ April 2003. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 17: 1625-38. doi:10.1056/NEJMoa021423. PMID 12711737. ^ Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D 2004. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291 24: 2978-84. doi:10.1001/jama.291.24.2978. PMID 15213209. ^ Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O 2006. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 17 6: 1695-702. doi:10.1681/ASN.2005060638. PMID 16641153. ^ Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R September 2005. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J. Urol. 174 3: 827-34. doi:10.1097/01.ju.0000169490.78443.59. PMID 16093964. ^ a b Schmidt DS, Salahudeen AK 2007. Obesity-survival paradox-still a controversy?. Semin Dial 20 6: 486-92. doi:10.1111/j.1525-139X.2007.00349.x. PMID 17991192. ^ Habbu A, Lakkis NM, Dokainish H October 2006. The obesity paradox: fact or fiction?. Am. J. Cardiol. 98 7: 944-8. doi:10.1016/j.amjcard.2006.04.039. PMID 16996880. ^ Romero-Corral A, Montori VM, Somers VK, et al 2006. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 9536: 666-78. doi:10.1016/S0140-67360669251-9. PMID 16920472. ^ Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA July 2008. Body mass index and mortality in heart failure: a meta-analysis. Am. Heart J. 156 1: 13-22. doi:10.1016/j.ahj.2008.02.014. PMID 18585492. ^ Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K February 2008. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity Silver Spring 16 2: 442-50. doi:10.1038/oby.2007.36. PMID 18239657. ^ Diercks DB, Roe MT, Mulgund J et al Jul 2006. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 152 1: 140-8. doi:10.1016/j.ahj.2005.09.024. PMID 16824844. ^ Sara Bleich, David Cutler, Christopher Murray, Alyce Adams March 2007. Working paper 12954: Why is the developed world obese?. National Bureau of Economic Research. ^ a b c d e f Pool, Robert 2001. Fat: fighting the obesity epidemic. Oxford, UK: Oxford University Press. ISBN 0-19-511853-7. ^ Keith SW, Redden DT, Katzmarzyk PT, et al 2006. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes Lond 30 11: 1585-94. doi:10.1038/sj.ijo.0803326. PMID 16801930. ^ National Control for Health Statistics. Nutrition For Everyone. Centers for Disease Control and Prevention. Retrieved on 2008-07-09. ^ Flegal KM, Carroll MD, Ogden CL, Johnson CL October 2002. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288: 1723-1727. doi:10.1001/jama.288.14.1723. PMID 12365955. ^ Wright JD, Kennedy-Stephenson J, Wang CY, McDowell MA, Johnson CL Feb 2004. Trends in intake of energy and macronutrients-United States, 1971-2000. MMWR Morb Mortal Wkly Rep 53 4: 80-2. ^ a b c d e f Caballero B 2007. The global epidemic of obesity: an overview. Epidemiol Rev 29: 1-5. doi:10.1093/epirev/mxm012. PMID 17569676. ^ Lin BH, Guthrie J and Frazao E 1999. Nutrient contribution of food away from home, in Frazão E: Agriculture Information Bulletin No. 750: America's Eating Habits: Changes and Consequences. Washington, DC: US Department of Agriculture, Economic Research Service, 213-239. ^ Brian Wansink and Mike Huckabee 2005, De-Marketing Obesity, California Management Review, 47:4 Summer, 6-18. ^ Pollan, Michael April 22, 2007. You Are What You Grow, New York Times. Retrieved on 2007-07-30. ^ Gortmaker SL, Must A, Sobol AM, Peterson K, Colditz GA, Dietz WH April 1996. Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med 150 4: 356-62. PMID 8634729. ^ Vioque J, Torres A, Quiles J December 2000. Time spent watching television, sleep duration and obesity in adults living in Valencia, Spain. Int. J. Obes. Relat. Metab. Disord. 24 12: 1683-8. PMID 11126224. ^ Tucker LA, Bagwell M July 1991. Television viewing and obesity in adult females PDF. Am J Public Health 81 7: 908-11. PMID 2053671. PMC:1405200. ^ a b Tjepkema M 2005-07-06. Measured Obesity-Adult obesity in Canada: Measured height and weight, Nutrition: Findings from the Canadian Community Health Survey. Ottawa, Ontario: Statistics Canada. ^ Levine JA, Lanningham-Foster LM, McCrady SK, Krizan AC, Olson LR, Kane PH, Jensen MD, Clark MM 2005. Interindividual variation in posture allocation: possible role in human obesity. Science 307 5709: 584-6. doi:10.1126/science.1106561. PMID 15681386. ^ Lopez R 2004. Urban sprawl and risk for being overweight or obese. Am J Public Health 94 9: 1574-9. PMID 15333317. ^ Farooqi S, O'Rahilly S December 2006. Genetics of obesity in humans. Endocr. Rev. 27 7: 710-18. doi:10.1210/er.2006-0040. PMID 17122358. ^ Frayling TM, Timpson NJ, Weedon MN, et al 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 5826: 889-94. doi:10.1126/science.1141634. PMID 17434869. ^ Rampersaud E, Mitchell BD, Pollin TI et al 2008. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med 16: 1791-97. doi:10.1001/archinte.168.16.1791. ^ Yang W, Kelly T, He J 2007. Genetic epidemiology of obesity. Epidemiol Rev 29: 49-61. doi:10.1093/epirev/mxm004. PMID 17566051. ^ Chakravarthy MV, Booth FW 2004. Eating, exercise, and thrifty genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J. Appl. Physiol. 96 1: 3-10. doi:10.1152/japplphysiol.00757.2003. PMID 14660491. ^ Rosén T, Bosaeus I, Tölli J, Lindstedt G, Bengtsson BA 1993. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin. Endocrinol. Oxf 38 1: 63-71. doi:10.1111/j.1365-2265.1993.tb00974.x. PMID 8435887. ^ Sobal J, Stunkard AJ March 1989. Socioeconomic status and obesity: a review of the literature. Psychol Bull 105 2: 260-75. doi:10.1037/0033-2909.105.2.260. PMID 2648443. ^ a b McLaren L 2007. Socioeconomic status and obesity. Epidemiol Rev 29: 29-48. doi:10.1093/epirev/mxm001. PMID 17478442. ^ Christakis NA, Fowler JH 2007. The Spread of Obesity in a Large Social Network over 32 Years. New England Journal of Medicine 357 4: 370-379. doi:10.1056/NEJMsa066082. PMID 17652652. ^ Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM November 1995. The influence of smoking cessation on the prevalence of overweight in the United States. N. Engl. J. Med. 333 18: 1165-70. PMID 7565970. ^ a b c d e Flier JS 2004. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116 2: 337-50. doi:10.1016/S0092-86740301081-X. PMID 14744442. ^ Hamann A, Matthaei S 1996. Regulation of energy balance by leptin. Exp. Clin. Endocrinol. Diabetes 104 4: 293-300. PMID 8886745. ^ Boulpaep, Emile L.; Boron, Walter F. 2003. Medical physiology: a cellular and molecular approach. Philadelphia: Saunders. ISBN 0-7216-3256-4. ^ a b c d e f Strychar I January 2006. Diet in the management of weight loss. CMAJ 174 1: 56-63. doi:10.1503/cmaj.045037. PMID 16389240. PMC:1319349. ^ Shick SM, Wing RR, Klem ML, McGuire MT, Hill JO, Seagle H April 1998. Persons successful at long-term weight loss and maintenance continue to consume a low-energy, low-fat diet. J Am Diet Assoc 98 4: 408-13. doi:10.1016/S0002-82239800093-5. PMID 9550162. ^ Tate DF, Jeffery RW, Sherwood NE, Wing RR April 2007. Long-term weight losses associated with prescription of higher physical activity goals. Are higher levels of physical activity protective against weight regain?. Am. J. Clin. Nutr. 85 4: 954-9. PMID 17413092. ^ Science-Based Solutions to Obesity: What are the Roles of Academia, Government, Industry, and Health Care? Proceedings of a symposium, Boston, Massachusetts, USA, March 10-11, 2004 and Anaheim, California, USA, October 2, 2004 July 2005. Am. J. Clin. Nutr. 82 1 Suppl: 207S-273S. PMID 16002825. ^ Weiss EC, Galuska DA, Kettel Khan L, Gillespie C, Serdula MK July 2007. Weight regain in U.S. adults who experienced substantial weight loss, 1999-2002. Am J Prev Med 33 1: 34-40. doi:10.1016/j.amepre.2007.02.040. PMID 17572309. ^ Anderson JW, Konz EC, Frederich RC, Wood CL November 2001. Long-term weight-loss maintenance: a meta-analysis of US studies. Am. J. Clin. Nutr. 74 5: 579-84. PMID 11684524. ^ Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C June 1995. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am. J. Epidemiol. 141 12: 1128-41. PMID 7771451. ^ Bravata DM, Sanders L, Huang J, et al April 2003. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 289 14: 1837-50. doi:10.1001/jama.289.14.1837. PMID 12684364. ^ Gwinup G 1987. Weight loss without dietary restriction: efficacy of different forms of aerobic exercise. Am J Sports Med 15 3: 275-9. PMID 3618879. ^ a b Fumento, Michael 1997. The Fat of the Land: Our Health Crisis and How Overweight Americans Can Help Themselves. Penguin Non-Classics, 126. ISBN 0-14-026144-3. ^ Shaw K, Gennat H, O'Rourke P, Del Mar C 2006. Exercise for overweight or obesity. Cochrane database of systematic reviews Online 4: CD003817. doi:10.1002/14651858.CD003817.pub3. PMID 17054187. ^ Lee L, Kumar S, Leong LC February 1994. The impact of five-month basic military training on the body weight and body fat of 197 moderately to severely obese Singaporean males aged 17 to 19 years. Int. J. Obes. Relat. Metab. Disord. 18 2: 105-9. PMID 8148923. ^ FDA|http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-fda-backgrounder.pdf ^ Rucker D, Padwal R, Li SK, Curioni C, Lau DC 2007. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 335 7631: 1194-9. doi:10.1136/bmj.39385.413113.25. PMID 18006966. ^ Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J 2005. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane database of systematic reviews Online 1: CD004096. doi:10.1002/14651858.CD004096.pub2. PMID 15674929. ^ UK Prospective Diabetes Study UKPDS Group 1998. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes UKPDS 34. Lancet 352 9131: 854-65. doi:10.1016/S0140-67369807037-8. PMID 9742977. ^ Fonseca V 2003. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am. J. Med. 115 Suppl 8A: 42S-48S. doi:10.1016/j.amjmed.2003.09.005. PMID 14678865. ^ Flanagan CM, Kaesberg JL, Mitchell ES, Ferguson MA, Haigney MC August 2008. Coronary artery aneurysm and thrombosis following chronic ephedra use. Int. J. Cardiol.. doi:10.1016/j.ijcard.2008.06.081. PMID 18718687. ^ Encinosa WE, Bernard DM, Chen CC, Steiner CA 2006. Healthcare utilization and outcomes after bariatric surgery. Medical care 44 8: 706-12. doi:10.1097/01.mlr.0000220833.89050.ed. PMID 16862031. ^ Sjöström L, Narbro K, Sjöström CD, et al August 2007. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357 8: 741-52. doi:10.1056/NEJMoa066254. PMID 17715408. ^ Sjöström L, Narbro K, Sjöström CD, et al 2007. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357 8: 741-52. doi:10.1056/NEJMoa066254. PMID 17715408. ^ a b Adams TD, Gress RE, Smith SC, et al 2007. Long-term mortality after gastric bypass surgery. N. Engl. J. Med. 357 8: 753-61. doi:10.1056/NEJMoa066603. PMID 17715409. ^ Klein S, Fontana L, Young VL, et al June 2004. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J. Med. 350 25: 2549-57. doi:10.1056/NEJMoa033179. PMID 15201411. ^ Giugliano G, Nicoletti G, Grella E, et al April 2004. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 57 3: 190-4. doi:10.1016/j.bjps.2003.12.010. PMID 15006519. ^ Snow V, Barry P, Fitterman N, Qaseem A, Weiss K 2005. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med 142 7: 525-31. PMID 15809464. Fulltext. ^ Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale.. Retrieved on 2007-05-22. ^ Pignone MP, Ammerman A, Fernandez L, et al 2003. Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force. American journal of preventive medicine 24 1: 75-92. doi:10.1016/S0749-37970200580-9. PMID 12554027. ^ a b c Anon 2005. OECD Factbook: Economic, Environmental and Social Statistics. Organization for Economic Co-operation and Development. ISBN 9264018697. ^ Childhood Obesity. Government of New South Wales 2006-08-03. Retrieved on 2008-06-22. ^ Tim Lobstein, Neville Rigby, Rachel Leach 2005-03-15. EU platform on diet, physical activity and health; International Obesity Task Force EU Platform Briefing Paper PDF, International Obesity Task Force. Retrieved on 2008-07-23. ^ Praween Kumar Agrawal 2002-05-23. Emerging Obesity in Northern Indian States: A Serious threat for Health PDF. IUSSP Conference, Bankik, June 10-12-2002. Retrieved on 2008-07-24. ^ Popkin, Barry September, 2007. The World Is Fat, Scientific American, pp. 94. ISSN 0036-8733. Retrieved on 2008-07-24. ^ WHO|url=http://www.wpro.who.int/NR/rdonlyres/B924BFA6-A061-43AE-8DCA-0AE82A8F66D2/0/obesityinthepacific.pdf ^ BBC England to have 13 m obese by 2010 25 August 2006 ^ Forecasting obesity to 2010 ^ Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM 2006. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 13: 1549-55. doi:10.1001/jama.295.13.1549. PMID 16595758. ^ International Obesity Taskforce|http://ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/iotf_en.pdf ^ Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH October 2002. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 288 14: 1758-61. PMID 12365960. ^ Satcher D 2001. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. U.S. Dept. of Health and Human Services, Public Health Service, Office of Surgeon General. ISBN 0-16051-005-8. ^ Brook Barnes 2007-07-18. Limiting Ads of Junk Food to Children, New York Times. Retrieved on 2008-07-24. ^ Tara McClair 2007-01-30. Junk-food ban receives mixed reactions in schools. Retrieved on 2008-07-24. ^ Brennan Ramirez LK, Hoehner CM, Brownson RC et al Dec 2006. Indicators of activity-friendly communities: an evidence-based consensus process. Am J Prev Med 31 6: 530-2. doi:10.1016/j.amepre.2006.07.026. PMID 17169714. ^ Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E April 2007. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children summary. CMAJ 176 8: S1-13. doi:10.1503/cmaj.061409. PMID 17420481. PMC:1839777. ^ 2004-02-11 Storing up problems; the medical case for a slimmer nation PDF, London: Royal College of Physicians. ISBN 1-86016-200-2. ^ Great Britain Parliament House of Commons Health Committee May 2004. Obesity - Volume 1 - HCP 23-I, Third Report of session 2003-04. Report, together with formal minutes. London, UK: TSO The Stationery Office. ISBN 0-21501-737-4. Retrieved on 2007-12-17. ^ Wanless, Sir Derek; John Appleby, Anthony Harrison, Darshan Patel 2007. Our Future Health Secured? A review of NHS funding and performance. London, UK: The King's Fund. ISBN 185717562X. Retrieved on 2007-12-17. ^ Finkelstein EA, Fiebelkorn IA, Wang G 2003. National medical spending attributable to overweight and obesity: how much, and who's paying. National medical spending attributable to overweight and obesity: how much, and who's paying Online May. ^ Obesity and Overweight: Economic Consequences. CDC. Retrieved on 2007-09-05. ^ van Baal PH, Polder JJ, de Wit GA, et al February 2008. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med. 5 2: e29. doi:10.1371/journal.pmed.0050029. PMID 18254654. PMC:2225430. ^ Chenoweth Associates Inc. 2005. The Economic Costs of Physical Inactivity, Obesity, and Overweight in California Adults PDF. Cancer Prevention and Nutrition Section, California Center for Physical Activity, California Department of Health Services, Sacramento, CA. Retrieved on 2008-07-23. ^ Ostbye T, Dement JM, Krause KM 2007. Obesity and workers' compensation: results from the Duke Health and Safety Surveillance System. Arch. Intern. Med. 167 8: 766-73. doi:10.1001/archinte.167.8.766. PMID 17452538. ^ Dannenberg AL, Burton DC, Jackson RJ 2004. Economic and environmental costs of obesity: the impact on airlines. American journal of preventive medicine 27 3: 264. doi:10.1016/j.amepre.2004.06.004. PMID 15450642. ^ a b 109th U.S. Congress 2005-2006 H.R. 554: 109th U.S. Congress 2005-2006 H.R. 554: Personal Responsibility in Food Consumption Act of 2005. GovTrack.us. Retrieved on 2008-07-24. ^ Lisa DiCarlo 2002-10-24. Why Airlines Can't Cut The Fat. Forbes.com. Retrieved on 2008-07-23. ^ Extra pounds mean insurance fees for Ala. workers. Associated Press Writer Aug 22 2008. Retrieved on 2008-09-09. ^ The Oxford English Dictionary website ^ University of Szeged. CGFA. ^ Breslow L Sep 1952. Public health aspects of weight control. Am J Public Health Nations Health 42 9: 1116-20. PMID 12976585. ^ a b c Woodhouse R 2008. Obesity in art: a brief overview. Front Horm Res 36: 271-86. doi:10.1159/000115370. PMID 18230908. ^ Critser, Greg 2004. Fat Land. London, England: Penguin Books Ltd. ISBN 0-14-101540-3. ^ Weintraub M May 1992. Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin. Pharmacol. Ther. 51 5: 581-5. PMID 1445528. ^ National Association to Advance Fat Acceptance, We come in all sizes, NAAFA, 2008. ^ Campos, Paul F. 2005. The Diet Myth. Gotham. ISBN 1-59240-135-X. ^ Gard, Michael 2005. The Obesity Epidemic: Science, Morality and Ideology. Routledge. ISBN 0415318963. ^ Douglas Martin 1991-07-31. About New York, New York Times. Retrieved on 2008-07-24. ^ Areton Jan 2002. Factors in the sexual satisfaction of obese women in relationships. Electronic Journal of Human Sexuality 5. Further reading Fumento, Michael 1997. The Fat of the Land: Our Health Crises and How Overweight Americans can Help Themselves. New York: Penguin Books. ISBN 0-140261443. Pool, Robert 2001. Fat: Fighting the Obesity Epidemic. Oxford, UK: Oxford University Press. ISBN 0-19-511853-7. Levy-Navarro, Elena 2008. The Culture of Obesity in Early and Late Modernity. Palgrave Macmillan. ISBN 0230601235. Kolata, Gina 2007. Rethinking Thin: The new science of weight loss - and the myths and realities of dieting. Picador. ISBN 0-312-42785-9. Peter G. Kopelman 2005. Clinical obesity in adults and children: In Adults and Children. Blackwell Publishing, 493. ISBN 140-511672-2. External links Wikimedia Commons has media related to: Obesity Wikinews Wikinews has related news: Obesity Look up Obesity in Wiktionary, the free dictionary. World Health Organization - Obesity pages Diet, Nutrition and the prevention of chronic diseases including obesity by a Joint WHO/FAO Expert consultation 2003. Obesity at Endotext.org International Task Force on Obesity The Obesity Society USA National Obesity Forum UK Australasian Society for the Study of Obesity v d e Nutrition disorders E40-68, 260-269 Malnutrition Kwashiorkor - Marasmus - Catabolysis Avitaminosis B vitamins: B1: Beriberi/Wernicke's encephalopathy, B2: Ariboflavinosis, B3: Pellagra, B6: Pyridoxine deficiency, B7: Biotin deficiency, B9: Folate deficiency, B12: Vitamin B12 deficiency other vitamins: A: Vitamin A deficiency/Bitot's spots, C: Scurvy, D: Rickets/Osteomalacia Mineral deficiency Zinc deficiency - Iron deficiency - Magnesium deficiency - Chromium deficiency - Keshan disease Hyperalimentation Obesity - Vitamin poisoning Hypervitaminosis A, Hypervitaminosis D, Hypervitaminosis E Retrieved from http://en..org/wiki/Obesity Categories: Obesity | Metabolic disorders | Health risks | Nutrition | Bariatrics | Body shapeHidden category: Semi-protected against vandalism Views Article Discussion View source History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page Languages العربية Bân-lâm-gú Bosanski БългарÑ?ки Català Česky Dansk Deutsch Eesti Español Esperanto Euskara Français Galego í•œêµì–´ हिनà¥?दी Hrvatski Bahasa Indonesia Ã?slenska Italiano עברית Basa Jawa Lietuvių Magyar Bahasa Melayu Nederlands 日本語 ‪Norsk bokmÃ¥l‬ Polski Português Runa Simi РуÑ?Ñ?кий Simple English SlovenÄ?ina SlovenÅ¡Ä?ina СрпÑ?ки / Srpski Suomi Svenska தமிழà¯? ไทย Tiếng Việt Türkçe УкраїнÑ?ька Walon ייִדיש ä¸æ–‡ This page was last modified on 9 September 2008, at 07:23
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie Video
The Power of You Video
Effects of MonaVie Active on Antioxidant Capacity in Humans
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.